Compare PAHC & GIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAHC | GIII |
|---|---|---|
| Founded | 1946 | 1956 |
| Country | United States | United States |
| Employees | 2475 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2014 | 2006 |
| Metric | PAHC | GIII |
|---|---|---|
| Price | $33.72 | $35.11 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 5 |
| Target Price | ★ $41.25 | $29.00 |
| AVG Volume (30 Days) | 277.6K | ★ 588.2K |
| Earning Date | 05-06-2026 | 06-05-2026 |
| Dividend Yield | 0.91% | ★ 1.29% |
| EPS Growth | ★ 1883.33 | N/A |
| EPS | ★ 1.90 | 1.50 |
| Revenue | $833,350,000.00 | ★ $2,957,012,000.00 |
| Revenue This Year | $17.03 | N/A |
| Revenue Next Year | $3.82 | N/A |
| P/E Ratio | ★ $18.18 | $23.93 |
| Revenue Growth | ★ 4.12 | N/A |
| 52 Week Low | $25.58 | $22.99 |
| 52 Week High | $60.08 | $36.53 |
| Indicator | PAHC | GIII |
|---|---|---|
| Relative Strength Index (RSI) | 51.33 | 59.39 |
| Support Level | $30.46 | $31.83 |
| Resistance Level | $34.57 | $36.53 |
| Average True Range (ATR) | 1.30 | 0.97 |
| MACD | 0.44 | 0.10 |
| Stochastic Oscillator | 67.13 | 75.93 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
G-III Apparel Group Ltd is an apparel manufacturing company. The company makes a wide range of apparel, footwear, and accessories that sells under its own brands, licensed brands, and private-label brands. It has a substantial portfolio for licensed and proprietary brands, anchored by brands: DKNY, Donna Karan, Karl Lagerfeld, Karl Lagerfeld Paris, Vilebrequin, and others. The reportable segments of the company are Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, and sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenue from Wholesale operations.